Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Medtronic plc (MDT)

87.295   1.525 (1.78%) 02-02 15:44
Open: 85.8 Pre. Close: 85.77
High: 87.85 Low: 85.7375
Volume: 5,229,129 Market Cap: 116,118(M)

Technical analysis

as of: 2023-02-02 3:13:18 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 102.6     One year: 119.84
Support: Support1: 80.67    Support2: 76.23
Resistance: Resistance1: 87.84    Resistance2: 102.6
Pivot: 81.85
Moving Average: MA(5): 84.33     MA(20): 81.27
MA(100): 81.82     MA(250): 92.06
MACD: MACD(12,26): 1.5     Signal(9): 0.9
Stochastic oscillator: %K(14,3): 95.8     %D(3): 94.6
RSI: RSI(14): 70.7
52-week: High: 114.3  Low: 75.76
Average Vol(K): 3-Month: 7,680 (K)  10-Days: 6,022 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MDT ] has closed above the upper band by 8.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 20.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 86.19 - 86.51 86.51 - 86.76
Low: 82.76 - 83.16 83.16 - 83.48
Close: 85.16 - 85.79 85.79 - 86.29

Company Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Headline News

Thu, 02 Feb 2023
Investing in Medtronic plc (MDT) is a safe bet with a significant edge - The Dwinnex

Thu, 02 Feb 2023
US defense chief affirms MDT commitment to PH vs. attacks -

Wed, 01 Feb 2023
Greenback JV girls survive Eagleton in final seconds - Maryville Daily Times

Tue, 31 Jan 2023
Will Medtronic (MDT) Beat Estimates Again in Its Next Earnings ... - Nasdaq

Tue, 31 Jan 2023
MDT Expands Relationships with Credit Unions, Prioritizes ... - Business Wire

Mon, 30 Jan 2023
MDT seeking public comment on reconstruction of I-90 rest stop ... - KULR-TV

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 1,340 (M)
Shares Float 1,330 (M)
% Held by Insiders 0.1 (%)
% Held by Institutions 83.2 (%)
Shares Short 8,040 (K)
Shares Short P.Month 7,920 (K)

Stock Financials

EPS 2.25
EPS Est Next Qtl 1.15
EPS Est This Year 4.63
EPS Est Next Year 5.13
Book Value (p.s.) 37.66
Profit Margin (%) 16.7
Operating Margin (%) 19.5
Return on Assets (ttm) 4.1
Return on Equity (ttm) 10
Qtrly Rev. Growth -7.7
Gross Profit (p.s.) 16.16
Sales Per Share 23.18
EBITDA (p.s.) 6.53
Qtrly Earnings Growth 24.7
Operating Cash Flow 7,140 (M)
Levered Free Cash Flow 4,200 (M)

Stock Valuations

PE Ratio 38.5
PEG Ratio 1.2
Price to Book value 2.31
Price to Sales 3.75
Price to Cash Flow 16.33

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-01-13
Ex-Dividend Date 2021-12-20
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.